Skip Navigation

Brain 2006 129(8):1938-1939; doi:10.1093/brain/awl198
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Engel, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engel, A. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Scientific Commentary

Light on limb-girdle myasthenia

The first 10% of the full text of this article appears below.

In the current issue of Brain, Slater et al. (2006)Go describe their findings in eight patients in seven kinships suffering from limb-girdle myasthenia (LGM). All eight had progressive weakness in a proximal limb-girdle distribution that began in the first or second decade of life, a decremental EMG response on 3 Hz stimulation and a favourable response to anticholinesterase medications. The oculobulbar muscles were spared except for slight facial weakness and ptosis in some patients. None had short-term fatigability induced by exercise, and none had detectable anti-AChR antibodies. Thus, they differed from most myasthenic patients in whom oculobulbar involvement heralds the onset of the disease and who typically experience increased weakness after exercise. In addition to thoroughly describing the clinical features of their patients, Slater et al. also investigated each patient by intracellular microelectrode studies of neuromuscular transmission . . . [Full Text of this Article]

Andrew G. Engel

Department of Neurology, Mayo Clinic Rochester, MN, USA

E-mail: age@mayo.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Hamuro, O. Higuchi, K. Okada, M. Ueno, S.-i. Iemura, T. Natsume, H. Spearman, D. Beeson, and Y. Yamanashi
Mutations Causing DOK7 Congenital Myasthenia Ablate Functional Motifs in Dok-7
J. Biol. Chem., February 29, 2008; 283(9): 5518 - 5524.
[Abstract] [Full Text] [PDF]